301 related articles for article (PubMed ID: 31601389)
1. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.
Garcia-Garcia HM; McFadden EP; von Birgelen C; Rademaker-Havinga T; Spitzer E; Kleiman NS; Cohen DJ; Kennedy KF; Camenzind E; Mauri L; Steg PG; Wijns W; Silber S; van Es GA; Serruys PW; Windecker S; Cutlip D; Vranckx P
JACC Cardiovasc Interv; 2019 Oct; 12(19):1954-1962. PubMed ID: 31601389
[TBL] [Abstract][Full Text] [Related]
2. Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Ndrepepa G; Colleran R; Braun S; Xhepa E; Hieber J; Cassese S; Fusaro M; Kufner S; Laugwitz KL; Schunkert H; Kastrati A
Catheter Cardiovasc Interv; 2018 Feb; 91(2):215-223. PubMed ID: 28500730
[TBL] [Abstract][Full Text] [Related]
3. Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study.
Christensen MK; Huang H; Torp-Pedersen C; Trydal T; Ravkilde J
BMC Cardiovasc Disord; 2016 Jun; 16():140. PubMed ID: 27305902
[TBL] [Abstract][Full Text] [Related]
4. Is periprocedural CK-MB a better indicator of prognosis after emergency and elective percutaneous coronary intervention compared with post-procedural cardiac troponins?
Gollop ND; Dhullipala A; Nagrath N; Myint PK
Interact Cardiovasc Thorac Surg; 2013 Nov; 17(5):867-71. PubMed ID: 23842761
[TBL] [Abstract][Full Text] [Related]
5. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
Farooq V; Serruys PW; Vranckx P; Bourantas CV; Girasis C; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; Dawkins KD; Mohr FW; James S; Ståhle E
Int J Cardiol; 2013 Oct; 168(6):5287-92. PubMed ID: 23993326
[TBL] [Abstract][Full Text] [Related]
6. Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends.
Tricoci P; Leonardi S; White J; White HD; Armstrong PW; Montalescot G; Giugliano RP; Gibson CM; Van de Werf F; Califf RM; Harrington RA; Braunwald E; Mahaffey KW; Newby LK
J Am Coll Cardiol; 2013 Jul; 62(3):242-251. PubMed ID: 23684676
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of creatine kinase-myocardial band isoenzyme elevation following percutaneous coronary intervention: a meta-analysis.
Jang JS; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Cho KI; Kim BH; Je HG; Park YH
Catheter Cardiovasc Interv; 2013 May; 81(6):959-67. PubMed ID: 22744792
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
Lindsey JB; Kennedy KF; Stolker JM; Gilchrist IC; Mukherjee D; Marso SP; Pencina MJ; Kleiman NS; Cohen DJ
Circ Cardiovasc Interv; 2011 Oct; 4(5):474-80. PubMed ID: 21972402
[TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis.
Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
Catheter Cardiovasc Interv; 2015 Mar; 85(4):564-72. PubMed ID: 25158217
[TBL] [Abstract][Full Text] [Related]
10. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
[TBL] [Abstract][Full Text] [Related]
11. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
Niccoli G; Sgueglia GA; Latib A; Crea F; Colombo A;
Catheter Cardiovasc Interv; 2014 Jan; 83(1):E37-44. PubMed ID: 23813627
[TBL] [Abstract][Full Text] [Related]
12. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
[TBL] [Abstract][Full Text] [Related]
13. Determinants and Prognostic Significance of Periprocedural Myocardial Injury in Patients With Successful Percutaneous Chronic Total Occlusion Interventions.
Lee SW; Lee PH; Kang SH; Choi H; Chang M; Roh JH; Yoon SH; Ahn JM; Park DW; Kang SJ; Kim YH; Lee CW; Park SW; Park SJ
JACC Cardiovasc Interv; 2016 Nov; 9(21):2220-2228. PubMed ID: 27832848
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.
Leonardi S; Thomas L; Neely ML; Tricoci P; Lopes RD; White HD; Armstrong PW; Giugliano RP; Antman EM; Califf RM; Newby LK; Mahaffey KW
J Am Coll Cardiol; 2012 Dec; 60(22):2296-304. PubMed ID: 23122801
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
[TBL] [Abstract][Full Text] [Related]
16. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
[TBL] [Abstract][Full Text] [Related]
17. Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCI.
Wang HY; Xu B; Dou K; Guan C; Song L; Huang Y; Zhang R; Xie L; Zhang M; Yan H; Yang W; Wu Y; Yang Y; Qiao S; Gao R; Stone GW
JACC Cardiovasc Interv; 2021 Aug; 14(15):1623-1634. PubMed ID: 34353593
[TBL] [Abstract][Full Text] [Related]
18. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker.
Okmen E; Kasikcioglu H; Sanli A; Uyarel H; Cam N
J Invasive Cardiol; 2005 Feb; 17(2):63-7. PubMed ID: 15687525
[TBL] [Abstract][Full Text] [Related]
19. Does creatine kinase-MB (CK-MB) isoenzyme elevation following percutaneous coronary intervention with drug-eluting stents impact late clinical outcome?
Javaid A; Buch AN; Steinberg DH; Pinto Slottow T; Roy P; Pichard AD; Satler LF; Kent KM; Gevorkian N; Xue Z; Suddath WO; Waksman R
Catheter Cardiovasc Interv; 2007 Nov; 70(6):826-31. PubMed ID: 17621656
[TBL] [Abstract][Full Text] [Related]
20. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.
Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND
J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]